Adaptive Biotechnologies to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
30 Agosto 2023 - 10:30PM
Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”)
(Nasdaq: ADPT), a commercial stage biotechnology company that aims
to translate the genetics of the adaptive immune system into
clinical products to diagnose and treat disease, today announced it
will be participating in the upcoming Morgan Stanley 21st Annual
Global Healthcare Conference in New York, New York
Adaptive Biotechnologies’ management is
scheduled to participate in a fireside chat on Wednesday, September
13th at 1:35 p.m. Eastern Time. Interested parties may access a
live and archived webcast of the presentation on the “Investors”
section of the company website at: www.adaptivebiotech.com.
About Adaptive Biotechnologies
Adaptive Biotechnologies (“we” or “our”) is a commercial-stage
biotechnology company focused on harnessing the inherent biology of
the adaptive immune system to transform the diagnosis and treatment
of disease. We believe the adaptive immune system is nature’s most
finely tuned diagnostic and therapeutic for most diseases, but the
inability to decode it has prevented the medical community from
fully leveraging its capabilities. Our proprietary immune medicine
platform reveals and translates the massive genetics of the
adaptive immune system with scale, precision and speed. We apply
our platform to partner with biopharmaceutical companies, inform
drug development, and develop clinical diagnostics across our two
business areas: Minimal Residual Disease (MRD) and Immune Medicine.
Our commercial products and clinical pipeline enable the diagnosis,
monitoring, and treatment of diseases such as cancer, autoimmune
disorders, and infectious diseases. Our goal is to develop and
commercialize immune-driven clinical products tailored to each
individual patient.
ADAPTIVE INVESTORSKarina Calzadilla, Vice
President, Investor
Relations201-396-1687investors@adaptivebiotech.com
ADAPTIVE MEDIAErica Jones, Associate Corporate
Communications
Director206-279-2423media@adaptivebiotech.com
Grafico Azioni Adaptive Biotechnologies (NASDAQ:ADPT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Adaptive Biotechnologies (NASDAQ:ADPT)
Storico
Da Giu 2023 a Giu 2024